InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-7.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Alter Jeffrey D., Director. Officer active across 3 companies, notably PROGENITY, INC.. Aggregated, 8 disclosures have been published. History available since 14 June 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
12,500 shares0Common StockSEC:0000950170-24-069926:0
12,500 shares0Common StockSEC:0000950170-23-028595:0
65 sharesSeries X Preferred StockSEC:0000899243-23-000961:0
96,154 shares0Common StockSEC:0000899243-22-023091:0
311 shares@ US$375.9350.0% of flowCommon StockSEC:0001156039-21-000086:0
311 shares@ US$375.9350.0% of flowCommon StockSEC:0001156039-21-000086
29,183 shares0Common StockSEC:0000899243-21-024202
29,183 shares0Common StockSEC:0000899243-21-024202:0
8 of 8 declarations
About Alter Jeffrey D.
Jeffrey D. Alter is a Board Member and EVP, IngenioRx & Anthem Health, involved with several companies including PROGENITY, INC., Anthem, Inc., and BIORA THERAPEUTICS, INC. He plays a key role in strategic direction and operational oversight, bringing his expertise in the healthcare sector.
